Results 191 to 200 of about 63,125 (287)

“Instead of just a drive by”: Clinician and birthing person perspectives on consent for toxicology testing during pregnancy

open access: yesPregnancy, Volume 2, Issue 3, May 2026.
Abstract Introduction Although state, federal, and professional guidelines stipulate the need for informed consent for toxicology testing during pregnancy, consent is often inadequately obtained. The objective of this study was to explore birthing person and obstetric clinician experiences with consent for toxicology testing during pregnancy.
Leah N. Schwartz   +7 more
wiley   +1 more source

Methods of Suicide Used by People With Cancer: A Scoping Review

open access: yesPsycho-Oncology, Volume 35, Issue 5, May 2026.
ABSTRACT Background Individuals diagnosed with cancer are at increased risk of suicide compared to the general population. Access to means is a key volitional risk factor for suicide and represents a modifiable target for prevention at a population level.
Doireann Ni Dhalaigh   +5 more
wiley   +1 more source

Racial and sex disparities in inpatient outcomes of patients with opioid overdose: a nationwide analysis. [PDF]

open access: yesProc (Bayl Univ Med Cent)
Quazi MA   +8 more
europepmc   +1 more source

Improving drug identification in overdose death surveillance by using clinical natural language processing models

open access: yesJournal of Forensic Sciences, Volume 71, Issue 3, Page 1329-1337, May 2026.
Abstract The rising rate of drug‐related deaths in the United States, largely driven by fentanyl, requires timely and accurate surveillance. However, critical overdose data are often buried in free‐text coroner reports, leading to delays and information loss when coded into ICD (International Classification of Disease)‐10 classifications.
Arthur J. Funnell   +8 more
wiley   +1 more source

Compiling Comprehensive Databases for Opioid Overdose Monitoring in a Fragmented Health Care System

open access: yes
Health Services Research, Volume 61, Issue 3, June 2026.
Dominic Hodgkin, Traci C. Green
wiley   +1 more source

Trends in toxicological findings and drug seizures of MDMA in New Zealand from 2010 to 2022

open access: yesJournal of Forensic Sciences, Volume 71, Issue 3, Page 1338-1350, May 2026.
Abstract 3,4‐Methylenedioxymethamphetamine (MDMA) or “ecstasy,” is a commonly used drug worldwide, including in New Zealand, where 4.8% of the population aged 15 years or over reported using it in a 2023/2024 survey. This study provides additional insights on MDMA prevalence data in New Zealand by reporting toxicology data from Coronial and driving ...
Thomas J. Sheehan   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy